Cargando…

ICAM3-Fc Outperforms Receptor-Specific Antibodies Targeted Nanoparticles to Dendritic Cells for Cross-Presentation

Optimal targeting of nanoparticles (NP) to dendritic cells (DCs) receptors to deliver cancer-specific antigens is key to the efficient induction of anti-tumour immune responses. Poly (lactic-co-glycolic acid) (PLGA) nanoparticles containing tètanus toxoid and gp100 melanoma-associated antigen, toll-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cruz, Luis J., Tacken, Paul J., van der Schoot, Johan M.S., Rueda, Felix, Torensma, Ruurd, Figdor, Carl G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540027/ https://www.ncbi.nlm.nih.gov/pubmed/31083610 http://dx.doi.org/10.3390/molecules24091825

Ejemplares similares

Harnessing human plasmacytoid dendritic cells as professional APCs
por: Tel, Jurjen, et al.
Publicado: (2012)

Eradicating cancer cells: struggle with a chameleon
por: Di, Jiabo, et al.
Publicado: (2011)

Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody
por: van Elsas, Marit J., et al.
Publicado: (2022)

Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection
por: Pittala, Srivamshi, et al.
Publicado: (2019)

The Dilemma of Cure and Damage in Oligodendroglioma: Ways to Tip the Balance Away from the Damage
por: Torensma, Ruurd
Publicado: (2018)

The Multiple Faces of Prostaglandin E2 G-Protein Coupled Receptor Signaling during the Dendritic Cell Life Cycle
por: De Keijzer, Sandra, et al.
Publicado: (2013)

Functional OCT4-specific CD4(+) and CD8(+) T cells in healthy controls and ovarian cancer patients
por: Di, Jiabo, et al.
Publicado: (2013)

The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues
por: Tel, Jurjen, et al.
Publicado: (2011)

Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4(+) T cells after FcγRII-mediated uptake
por: Benitez-Ribas, Daniel, et al.
Publicado: (2006)

Triggering of FcGR during dendritic cell maturation leads to a decreased expression of the chemokines DC-CK1, ELC and TARC
por: Radstake, TRDJ, et al.
Publicado: (2004)

Fc-engineering significantly improves the recruitment of immune effector cells by anti-ICAM-1 antibody MSH-TP15 for myeloma therapy
por: Klausz, Katja, et al.
Publicado: (2020)

Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanisms
por: Pellerin, Alex, et al.
Publicado: (2015)

Ag nanoparticles outperform Au nanoparticles for the use as label in electrochemical point-of-care sensors
por: Beck, Franziska, et al.
Publicado: (2021)

Activation of NMDA receptors promotes dendritic spine development through MMP-mediated ICAM-5 cleavage
por: Tian, Li, et al.
Publicado: (2007)

Sustained high expression of Fcγ receptorII (CD32) on dendritic cells (DCs) in patients with rheumatoid arthritis (RA)
por: Radstake, TRDJ, et al.
Publicado: (2002)

Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies
por: van der Horst, Hilma J., et al.
Publicado: (2020)

A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries
por: Klausz, Katja, et al.
Publicado: (2017)

The dendritic cell cytoskeleton promotes T cell adhesion and activation by constraining ICAM-1 mobility
por: Comrie, William A., et al.
Publicado: (2015)

Toll-like receptor triggering in cord blood mesenchymal stem cells
por: van den Berk, Lieke CJ, et al.
Publicado: (2009)

Human Plasmacytoid Dendritic Cells: From Molecules to Intercellular Communication Network
por: Mathan, Till S. M., et al.
Publicado: (2013)

The influence of antibody engineering on Fc conformation and Fc receptor binding properties: Analysis of FcRn-binding engineered antibodies and an Fc fusion protein
por: Suzuki, Takuo, et al.
Publicado: (2021)

The Tetraspanin Protein CD37 Regulates IgA Responses and Anti-Fungal Immunity
por: van Spriel, Annemiek B., et al.
Publicado: (2009)

ICAM-1 and ICAM-2 Are Differentially Expressed and Up-Regulated on Inflamed Pulmonary Epithelium, but Neither ICAM-2 nor LFA-1: ICAM-1 Are Required for Neutrophil Migration Into the Airways In Vivo
por: Chong, Deborah L. W., et al.
Publicado: (2021)

Characterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-1 and ICAM-2 in immune responses
Publicado: (1994)

Fcγ Receptors and Cross-Presentation in Dendritic Cells
por: Amigorena, Sebastian
Publicado: (2002)

Universal Antibody Conjugation to Nanoparticles Using the Fcγ Receptor I (FcγRI): Quantitative Profiling Of Membrane Biomarkers
por: Kim, Chloe, et al.
Publicado: (2014)

Interaction of Helicobacter pylori with C-Type Lectin Dendritic Cell-Specific ICAM Grabbing Nonintegrin
por: Miszczyk, Eliza, et al.
Publicado: (2012)

Tumoricidal activity of human dendritic cells
por: Tel, Jurjen, et al.
Publicado: (2014)

Naturally circulating dendritic cells to vaccinate cancer patients
por: Bol, Kalijn F., et al.
Publicado: (2013)

Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential
por: Stapleton, Nigel M., et al.
Publicado: (2011)

Proteome Based Construction of the Lymphocyte Function-Associated Antigen 1 (LFA-1) Interactome in Human Dendritic Cells
por: Eich, Christina, et al.
Publicado: (2016)

Fc-Glycosylation in Human IgG1 and IgG3 Is Similar for Both Total and Anti-Red-Blood Cell Anti-K Antibodies
por: Sonneveld, Myrthe E., et al.
Publicado: (2018)

Toxoplasma effector-induced ICAM-1 expression by infected dendritic cells potentiates transmigration across polarised endothelium
por: Ross, Emily C., et al.
Publicado: (2022)

Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G
por: Einarsdottir, Helga K., et al.
Publicado: (2012)

The role of ICAM-2 in neuroblastoma
por: Yoon, Karina J., et al.
Publicado: (2015)

The Extracellular Domain of CD83 Inhibits Dendritic Cell–mediated T Cell Stimulation and Binds to a Ligand on Dendritic Cells
por: Lechmann, Matthias, et al.
Publicado: (2001)

Rational engineering of Fc/Fc receptor interactions to improve antibody potency
por: Doberstein, S, et al.
Publicado: (2003)

Dual Site-Specific Chemoenzymatic Antibody Fragment Conjugation Using CRISPR-Based Hybridoma Engineering
por: Le Gall, Camille M., et al.
Publicado: (2021)

Bacillus subtilis Spore-Trained Dendritic Cells Enhance the Generation of Memory T Cells via ICAM1
por: Lin, Jian, et al.
Publicado: (2021)

Multiscale imaging of therapeutic anti-PD-L1 antibody localization using molecularly defined imaging agents
por: Hagemans, Iris M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4s21np2jqau4c9ijo893cell6g